Cargando…

m(6)A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD), the most common type of lung cancer, poses a significant threat to the life of patients. N6-methyladenosine modification is the most abundant epigenetic modification and may play an important role in the lung carcinogenesis. IGF2BP1 is a newly discovered m6A-b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Hansheng, Xu, Haijie, Huang, Shujie, Tang, Yong, Tang, Jiming, Zhou, Haiyu, Xie, Liang, Qiao, Guibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554348/ https://www.ncbi.nlm.nih.gov/pubmed/36249006 http://dx.doi.org/10.3389/fonc.2022.989817

Ejemplares similares

Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma
por: Wu, Hansheng, et al.
Publicado: (2021)

IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N(6)-methyladenosine-dependent binding
por: Zhang, Junzhe, et al.
Publicado: (2022)

The staging performance of a modified tumor-node-metastasis staging system incorporated with lymphovascular invasion in patients with esophageal squamous cell carcinoma
por: Zhuang, Weitao, et al.
Publicado: (2022)

IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism
por: Pu, Jian, et al.
Publicado: (2020)

Inhibition of the mRNA-Binding Protein IGF2BP1 Suppresses Proliferation and Sensitizes Neuroblastoma Cells to Chemotherapeutic Agents
por: Biegel, Jason M., et al.
Publicado: (2021)

A novel prognostic model: which group of esophageal squamous cell carcinoma patients could benefit from adjuvant chemotherapy
por: Zhou, Zihao, et al.
Publicado: (2022)

Factors influencing negative surgical outcomes in adult pectus excavatum patients undergoing Nuss procedure
por: Gao, Zhen, et al.
Publicado: (2021)

METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification
por: Guo, Zhenyun, et al.
Publicado: (2022)

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma
por: Liu, Huidi, et al.
Publicado: (2020)

Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma
por: Barghash, Ahmad, et al.
Publicado: (2016)

Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma
por: Martinelli, Marcella, et al.
Publicado: (2022)

RNA-Binding Protein IGF2BP1 Associated With Prognosis and Immunotherapy Response in Lung Adenocarcinoma
por: Liu, JinFeng, et al.
Publicado: (2022)

Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk
por: Tang, Weifeng, et al.
Publicado: (2018)

Knockdown of m6A Reader IGF2BP3 Inhibited Hypoxia-Induced Cell Migration and Angiogenesis by Regulating Hypoxia Inducible Factor-1α in Stomach Cancer
por: Jiang, Libin, et al.
Publicado: (2021)

Transfer of IGF2BP3 Through Ara-C-Induced Apoptotic Bodies Promotes Survival of Recipient Cells
por: Gou, Junjie, et al.
Publicado: (2022)

Analysis of miRNA-mRNA Crosstalk in Radiation-Induced Mouse Thymic Lymphomas to Identify miR-486 as a Critical Regulator by Targeting IGF2BP3 mRNA
por: Zhao, Hainan, et al.
Publicado: (2021)

A pan-cancer analysis of ABI3BP: a potential biomarker for prognosis and immunoinfiltration
por: Feng, Yan, et al.
Publicado: (2023)

IGF2BP3 is an essential N(6)-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
por: Xu, Xin, et al.
Publicado: (2022)

Diagnostic Utility of IGF2BP1 and Its Targets as Potential Biomarkers in ETV6-RUNX1 Positive B-Cell Acute Lymphoblastic Leukemia
por: Sharma, Gunjan, et al.
Publicado: (2021)

m(6)A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma
por: Fang, Han, et al.
Publicado: (2023)

Identification of IRAK1BP1 as a candidate prognostic factor in lung adenocarcinoma
por: Guo, Lei, et al.
Publicado: (2023)

Long noncoding RNA CERS6‐AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA
por: Bao, Gang, et al.
Publicado: (2019)

MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification
por: Shi, Wenjing, et al.
Publicado: (2022)

Two Isoforms of the mRNA Binding Protein IGF2BP2 Are Generated by Alternative Translational Initiation
por: Le, Hang T. T., et al.
Publicado: (2012)

IGF2BP2 acts as a m(6)A modification regulator in laryngeal squamous cell carcinoma through facilitating CDK6 mRNA stabilization
por: Tang, Xiaojun, et al.
Publicado: (2023)

Investigation of Igf-1, Igf-Bp3 and Igf-Bp5 levels in umbilical cord blood of infants with developmental dysplasia of the hip
por: DEMİREL, Esra, et al.
Publicado: (2023)

Upregulation of IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression That Is Related to Cell Proliferation, Metastasis and Tumor-Infiltrating Immune Cells
por: Zhou, Lijie, et al.
Publicado: (2022)

Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival
por: Schaeffer, David F, et al.
Publicado: (2010)

Expression pattern analysis of m6A regulators reveals IGF2BP3 as a key modulator in osteoarthritis synovial macrophages
por: Lu, Yuheng, et al.
Publicado: (2023)

An oncopeptide regulates m(6)A recognition by the m(6)A reader IGF2BP1 and tumorigenesis
por: Zhu, Song, et al.
Publicado: (2020)

Transcriptome-wide m(6)A methylome analysis uncovered the changes of m(6)A modification in oral pre-malignant cells compared with normal oral epithelial cells
por: Chen, Xun, et al.
Publicado: (2022)

Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer
por: Huang, Xinwei, et al.
Publicado: (2018)

The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma
por: Yao, Qi, et al.
Publicado: (2021)

IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation
por: Cao, Pei, et al.
Publicado: (2022)

LncRNA-AC068228.1 Is a Novel Prognostic Biomarker That Promotes Malignant Phenotypes in Lung Adenocarcinoma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Identification of lymph node metastasis-related genes and patterns of immune infiltration in colon adenocarcinoma
por: Zhang, Haoxiang, et al.
Publicado: (2023)

N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma
por: Zhao, Yibin, et al.
Publicado: (2022)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

Identification of the function and mechanism of m6A reader IGF2BP2 in Alzheimer’s disease
por: Deng, Yanyao, et al.
Publicado: (2021)

Malignant priapismus induced by adenocarcinoma of the prostate
por: Sibarani, Jupiter, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h2es3fuk4dhk0frggjrmdt129o